Skip to main content
. Author manuscript; available in PMC: 2012 Jul 12.
Published in final edited form as: Clin Cancer Res. 2010 Nov 9;16(22):5581–5590. doi: 10.1158/1078-0432.CCR-10-0851

Fig. 3.

Fig. 3

Scatter plot of patient number [adenocarcinomas of known EGFR and KRAS status (marked)] versus smoking status in pack-years. The vertical line separates ALK-positive from ALK-negative cases. ALK FISH positivity was statistically significantly enriched among never/light smokers (<10 pack-years; P = 0.0004, Fisher’s exact test; proportion positive among never/light smoking adenocarcinomas = 13 of 33, 39%; proportion positive among those with >10–pack-year smoking history = 0 of 22).